U.K. Judges Rule Against Pfizer in Lyrica Patent Appeal

Oct 15, 2016

Bloomberg

Pfizer Inc. lost an appeal in a U.K. patent dispute over Lyrica, which generated sales of $4.8 billion last year. According to a Bloomberg article, three London judges upheld a 2015 ruling that Allergan’s Actavis unit didn’t infringe Pfizer patents with its drug pregabalin. Teva bought that business this year.

Pfizer has also sued Dr. Reddy’s Laboratories and Teva Pharmaceutical Industries Ltd. over their generic pregabalin products.

Read the Bloomberg story

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments